Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000261723

Medchemexpress LLC Camonsertib | 2417489-10-0 | MFCD34578462 | 100.0% | C21H26N6O3 | 10MG
SDP

Supplier:  Medchemexpress LLC HY13960910MG

Encompass_Preferred

Camonsertib is an orally active, selective ATR kinase inhibitor developed for oncology research and clinical investigation. It exhibits low-nanomolar biochemical potency against ATR, reported selectivity versus related kinases, and has shown antitumor activity in preclinical and early clinical studies. The compound is supplied as a high-purity solid for research use only.

  • Potent ATR inhibition with low-nanomolar biochemical potency.
  • High selectivity versus related kinases, limiting off-target effects.
  • Demonstrated antitumor activity in preclinical and early clinical evaluations.
  • Provided as a high-purity solid suitable for laboratory research.
  • Available in small research-scale quantities for experimental studies.

Catalog No. 50-002-61723


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.